Search results
Added:
2 years ago
In this video, Dr Michael R Gold (Medical University of South Carolina, Charleston, SC, US) shares the primary results of the Smart-CRT Trial. The study investigated the efficacy of an atrioventricular optimization algorithm to improve reverse remodeling among patients undergoing cardiac resynchronization therapy (CRT) in the presence of interventricular electrical delay.
Discussion Points…
View more
Added:
3 years ago
Mechanical dyssynchrony, ie nonsynchronous contraction of the wall segments of the left ventricle (intraventricular) or between the left and right ventricles (interventricular), impairs systolic function and ventricular filling, increases wall stress and worsens mitral regurgitation. It is most readily defined by the presence of QRS widening and left bundle branch block (LBBB) configuration on…
View more
Added:
1 year ago
EHRA 23 - Dr Marco Bergonti (Istituto Cardiocentro Ticino, CH) to discuss the key takeaways from the ANTWOORD II Trial.
In this study, 605 heart failure patients undergoing atrial fibrillation ablation were enrolled to receive an ANTWERP Score, which aimed to predict LVEF recovery. 70% of patients were categorised as 'responders', patients identified as those who could benefit the most from AF…
View more
Added:
3 years ago
Experimental and clinical studies have demonstrated that enhanced sympathetic autonomic nervous system (SANS) activity can destabilise myocardial repolarisation,1–4 increasing vulnerability to developing fatal cardiac arrhythmias.5–8 Accordingly, assessment of SANS activity has always been a major goal for cardiac risk stratification methods. Various non-invasive methods including assessment of…
View more
Added:
2 years ago
Added:
3 years ago
His bundle pacing in humans was first described in 1970 by Narula et al.1 They demonstrated that it was possible to stimulate the His bundle to produce normal physiological ventricular activation via the His-Purkinje system. However, the first report of permanent His bundle pacing, by Deshmukh et al., did not occur until 2000.2 In that study, His pacing was performed in a series of patients with…
View more
Added:
1 year ago
In this short interview from HRS 2022, Dr Pugazhendi Vijayaraman (Geisinger Heart Institute, Wilkes-Barre, Pennsylvania, US) outlines the findings from the CSP-SYNC trial which investigated the effects of conduction system pacing as compared to conventional biventricular pacing in patients with heart failure with preserved ejection fraction (HFpEF).
Discussion Points:
1. Aim of this study
2…
View more
Added:
1 year ago
Dr Pugazhendi Vijayaraman (Geisinger Heart Institute, Wilkes-Barre, Pennsylvania, US) joins us from HRS 2022 to discuss the real-world data from an international study assessing the outcomes of rescue LBBAP in patients with coronary sinus lead failure, or those who did not respond to BIV-CRT.
Discussion points:
1. Importance of this study
2. Patient cohort, study design and endpoints
3. Key…
View more
Added:
3 years ago
AF is the most common rhythm disorder. It is estimated AF will affect 6–12 million Americans by 2050 and 17.9 million Europeans by 2060.1–4 AF is responsible for significant morbidity, mortality and healthcare costs.5–7 Heart failure with reduced ejection fraction (HFrEF) is also a rising epidemic that will afflict over 8 million Americans by 2030.8 AF is common in patients with HFrEF9,10 and…
View more
Added:
3 years ago
With 2016’s last quarter upon us, the Board of the European Heart Rhythm Association (EHRA) and I are happy to be sharing the latest updates and insights from this busy and fruitful year with the readers of Arrhythmia & Electrophysiology Review.
The EHRA has intensified its involvement in clinical trials. Following our longstanding support of the Early Treatment of Atrial Fibrillation for Stroke…
View more
